$14.60-2.60%
2026-10-05 closeAvalo Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$69M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Avalo Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$69M.